subtenon dexmedetomidine in vitreoretinal surgery

Effect of Subtenon dexmedetomidine on perioperative analgesia in vitreoretinal surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201506001151337

Enrollment

Registered

2015-05-28

Start date

2014-03-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Post-operative pain after vitreoretinal surgery

Interventions

bupivacaine 0.5%+lidocaine2%

dexmeditomidine+bupivacaine+lidocaine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA grade I¿III and aged 18¿70 years of both sex scheduled for vitreoretinal surgery with sub-Tenon¿s anesthesia

Exclusion criteria

Exclusion criteria: the usual contraindications for regional anesthesia, coagulation abnormalities, impaired mental status, uncontrolled glaucoma, recent surgical procedure on the same eye, allergy to the studied drugs and refusal of the patient.

Design outcomes

Primary

Measure	Time frame
postoperative pain score	—

Countries

Egypt

Contacts

Public Contactosama elmorsy

lecturer of ophthalmology, menofiya faculty of medicine

osamaelmorsy@yahoo.com00201227968203

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026